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Period3 (Per3) is one of the most robustly rhythmic genes in humans and animals. It plays a signiﬁcant
role in temporal organisation in peripheral tissues. The effects of PER3 variants on many phenotypes have
been investigated in targeted and genome-wide studies. PER3 variants, especially the human variable
number tandem repeat (VNTR), associate with diurnal preference, mental disorders, non-visual re-
sponses to light, brain and cognitive responses to sleep loss/circadian misalignment. Introducing the
VNTR into mice alters responses to sleep loss and expression of sleep homeostasis-related genes. Several
studies were limited in size and some ﬁndings were not replicated. Nevertheless, the data indicate a
signiﬁcant contribution of PER3 to sleep and circadian phenotypes and diseases, which may be con-
nected by common pathways. Thus, PER3-dependent altered light sensitivity could relate to high retinal
PER3 expression and may contribute to altered brain response to light, diurnal preference and seasonal
mood. Altered cognitive responses during sleep loss/circadian misalignment and changes to slow wave
sleep may relate to changes in wake/activity-dependent patterns of hypothalamic gene expression
involved in sleep homeostasis and neural network plasticity. Comprehensive characterisation of effects of
clock gene variants may provide new insights into the role of circadian processes in health and disease.
© 2017 Elsevier Ltd. All rights reserved.Introduction
Disruption of sleep and circadian rhythms is prominent in
mental and physical diseases. Inter-individual variation in sleep
and circadian rhythmicity and risk for physical and mental diseases
is in part explained by genetic variation. Here we review how
variation in the PERIOD3 (PER3) gene contributes to inter-individual
differences in sleep and circadian rhythmicity phenotypes and
disease risk. We pay attention to the wide range of phenotypic
associations and attempt to understand how these associations
may be connected through common pathways.
PER3 is a molecular component of the circadian clock
PER3 is a molecular component of the circadian clock and is a
member of the protein-binding family that contain PAS (PER-ARNT-
SIM) domains which enable protein dimerization. It binds withrcher).
N, et al., Phenotyping of PER
ews (2017), https://doi.org/10other PERIOD and CRYPTOCHROME (CRY) proteins in the negative
limb of the transcriptional/translational feedback loop and inhibits
the expression of core clock genes and clock-controlled genes by
the heterodimer transcription factor CLOCK/BMAL1 which binds to
promoter region E-box motifs (Fig. 1) [1]. Recently, electron mi-
croscopy has been used with mouse liver cell extracts to show that
PER3 protein forms part of a mature cytoplasmic multi-globular
complex with PER1, PER2, CRY1, CRY2, casein kinase 1 delta
(CK1d) and that this complex migrates to the nucleus to bind to and
inhibit CLOCK/BMAL1 [2].
Evolutionary history of PER3
Three Per paralogues exist in most vertebrates and have likely
evolved via two genome duplication events from a single ancestral
gene [3]. After such evolutionary events, duplicated genes are
commonly lost if they confer no diverse functional adaptation, or
are retained if accumulating genetic variation provides a selective
advantage. Because PER3 exists in humans, this implies that func-
tions associated with it have been positively selected and main-
tained, unlike PER4 which has been lost from the genome [3].3 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
Abbreviations
ASPD advanced sleep phase disorder
BDNF brain derived neurotrophic factor
BMI body mass index
CK1 casein kinase 1
CRSWD circadian rhythm sleepewake disorders
CRY cryptochrome
CT circadian time
dLAN dim light at night
DSPD delayed sleep phase disorder
EEG electroencephalogram
FA fractional anisotropy
fMRI functional magnetic resonance imaging
GWAS genome-wide association study
HCC hepatocellular carcinoma




NREM non rapid eye movement
OVLT organum vasculosum lamina terminalis
PER period
PSD partial sleep deprivation
PVT psychomotor vigilance task
RD radial diffusivity
REM rapid eye movement
SAD seasonal affective disorder
SCN suprachiasmatic nucleus
SD sleep deprivation
SNP single nucleotide polymorphism
SWA slow wave activity
SWE slow wave energy
SWS slow wave sleep
TSD total sleep deprivation
VLPO ventrolateral preoptic nucleus
VNTR variable number tandem repeat
WM white matter
S.N. Archer et al. / Sleep Medicine Reviews xxx (2017) 1e182PER1 or PER2 are essential for normal circadian function but PER3
alone cannot drive the central circadian clock in the suprachiasmatic
nuclei (SCN) of the hypothalamus [4]. The absence of PER3 has only
minor effects on behaviour driven by the SCN clock [5]. However, in
peripheral tissues, circadian period and phase are disrupted in Per3
knock out (KO) mice [6]. Thus, the evolutionary selective pressure to
retain the duplicated Per3 gene is unlikely to have derived from its
role within the central, hypothalamic clock, but more likely came
fromnovel functions inperipheral clocks andassociatedphenotypes.
These phenotypes include diurnal preference, sleep homeostasis,
circadian rhythm sleepewake disorders (CRSWDs), cognitive per-
formance, light sensitivity, mental disorders, and cancer. Thus,
although PER3 has often been neglected as a circadian clock gene,
there is a wealth of data that links it with physiological and health
phenotypes. The question remains, what are the characteristics of
PER3 and the underlying mechanisms that give rise to this?
PER3 is one of the most highly rhythmic genes in the CNS and
periphery
In mice, robust expression levels of Per3 have been found in the
CNS including the ventromedial hypothalamic nucleus, gyrus den-
tatus, arcuate nucleus and medial amygdaloid nucleus, with moder-
ate expression levels in the cingulate cortex, hippocampal pyramidal
cells, cerebellar cortex and the nucleus tractus solitarius [7]. Per3 is
also strongly expressed in peripheral mouse tissues, including in
heart, lung, liver, skeletal muscle, kidney and testis [7,8]. Robust,
rhythmic expression of Per3 occurs in the SCN and the organum
vasculosum lamina terminalis (OVLT), with peak expression at
circadian time (CT) 4 and 8, respectively (CT0¼ subjective dawn) [7].
The peak of rhythmic expression of Per3 in peripheral mouse tissues
and certain CNS regions (liver, skeletalmuscle, testis, arcuate nucleus,
ventromedial hypothalamic nucleus, and retina) appears shifted
relative to the SCN to between CT9 and 21 [7,8]. Of interest, Per3
expression in the rat sleep-related ventrolateral preoptic nucleus
(VLPO) is 12 h out of phase with its expression in the SCN [9].
The role of PER3 in the periphery
The role of PER3 in the SCN may be redundant but its contri-
bution to peripheral clocks is more signiﬁcant. In Per3 KO mice, the
period and phase of tissue explants from pituitary, liver, lung,Please cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10adrenal, oesophagus, aorta, thymus, arcuate complex, and gonadal
adipose were signiﬁcantly shorter and/or advanced compared to
wild type mice [6,10]. Period length was also shorter in ﬁbroblast,
adipocyte, and hepatocyte cell cultures where Per3 had been
silenced [11]. SCN explants from Per3 KO mice showed only a small
reduction in luciferase reporter period [11], which were similar to
previous reports for Per3 KO locomotor activity period [5]. How-
ever, when explanted SCN cells were dissociated they showed a
substantially shorter luciferase reporter period in Per3 KO
compared to wild type (25.58 ± 0.12 h vs. 27.23 ± 0.24,
mean ± SEM) [11]. All these ﬁndings underline a potential promi-
nent role for PER3 in the periphery, but also in the SCN, where its
importance only becomes apparent when the coupling between
pacemaker neurons in the intact tissue is removed.
PER3 and light phenotypes
Unlike Per1 and Per2, Per3 expression in the SCN is not induced
by light [7,8]. Nevertheless, high levels of rhythmic expression of
Per3 were found in the mouse retina and speciﬁcally in photore-
ceptors [8,12], as well as in rat pineal [13]. In human tissues the
highest levels of PER3 are recorded in retina, thyroid and pineal,
while in the mouse the highest levels are found in the salivary and
lacrimal glands, the pituitary and adrenal glands, and many com-
partments of the eye including the retina (BioGPS GeneAtlas,
biogps.org). Thus, in addition to its wide expression throughout the
body (Fig. 1), PER3 is also speciﬁcally present in tissues involved
with light-dependent phenotypes. This may be related to some of
the light-dependent phenotypes observed in Per3 KOmice [14] and
also in humans [15,16] (see below).
Rhythmic expression of PER3 in human and animal tissues
In humans, assessment of the time course of PER3 across the 24-
h day has been carried out by targeted quantitative polymerase
chain reaction (PCR) in white adipose tissue [17] and blood cells
(e.g., [18,19]), and by genome-wide microarray transcriptomic
proﬁling in hair follicles [20], keratinocytes [21], post-mortem
brain tissue [22e24], bone cell cultures [25], and whole blood in
different sleepewake conditions [26e28]. A novel machine
learning-based approach has also been used to order samples with
no time stamps to form a time series showing robust expression of3 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
Fig. 1. The circadian molecular clock and the inﬂuence of PER3 on phenotypes and disease in peripheral tissues. The circadian clock consists of positive and negative integrated
transcription and translation feedback loops. The transcription factors BMAL1 and CLOCK bind to E-box motifs in the promoters of clock controlled genes (CCGs) including the core
clock genes PER1/2/3, CRY1/2, REVERB and ROR. ROR and REVERB proteins feedback and bind to ROR/REVERB response elements (RRE) in the promoter of BMAL1 and either enhance
or suppress its expression, respectively. PER and CRY proteins form complexes together with CK1, which phosphorylates them determining stability and proteosomal turnover (thin
blue arrow). PER3 stabilises PER1/2 in PER/CRY complexes, which feedback and suppress the promotion by BMAL1/CLOCK (thick red line). PER3 variants can affect the stability of
PER3 causing greater degradation (thick blue arrow), reduced PER1/2 stability, and reduced suppression of BMAL1/CLOCK (thin red line). This provides a mechanism by which PER3
can inﬂuence circadian period and phase in peripheral tissues (including the brain) and also the expression of many CCGs. The inﬂuence of PER3 variants on the circadian clock and
CCGs potentially underlies the wide range of phenotypes and disease conditions that have been associated with PER3 variants. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
S.N. Archer et al. / Sleep Medicine Reviews xxx (2017) 1e18 3PER3 also in human liver biopsies [29]. An analysis of a subset of
these human datasets, together with 16 mouse time series data
from different tissues and conditions revealed that PER3 is the third
most robustly expressed clock gene (after NR1D1 and NR1D2), be-
ing rhythmic in 94% of mouse tissue time series and 86% of the few
human tissues investigated (Fig. 2) [30]. These studies all conﬁrm
PER3 as ranking among the top rhythmically expressed genes in
peripheral tissues. The peak of PER3 expression in human non-
brain tissues is reported to be around relative clock time 6e10
(~4e8 am; Fig. 2), while in the brain PER3 expression is around
relative clock time 4e6 (~4e6 hours after onset of pseudoday; Fig.
2), although given the sampling resolution it remains to be ﬁrmly
established whether these differences are robust. In a study of
prefrontal cortex post-mortem samples from young and old in-
dividuals, core clock gene expression was found to be phase-
advanced and reduced in amplitude in older individuals except
for PER3, which remained unchanged [24].
What drives the robust, rhythmic expression of PER3?
A recent detailed analysis of transcription factor units within the
human PER3 transcription regulatory region has revealed three E-Please cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10box and two D-box motifs [31]. CLOCK/BMAL1 and DBP (D-box
binding PAR BZIP transcription factor), independently bind to the E
box and D box motifs, respectively, to drive expression of PER3. By
removing different combinations of the motifs from the PER3 reg-
ulatory region, Matsumura et al. showed that the motifs contrib-
uted differentially to the overall amplitude and phase of expression,
and that their combined activation led to robust, high amplitude
expression. This observation likely accounts for the consistent
observation in the literature of robust PER3 expression.
PER3 polymorphisms
The study of sequence variation within a gene and genotype/
phenotype associations is a powerful way to identify functional
characteristics of the encoded protein. The human PER3 sequence
together with a catalogue of its polymorphismswas published soon
after it was ﬁrst isolated in mice [32]. Compared with PER1 and
PER2, PER3 is highly polymorphic [33] and subsequently many
more coding and non-coding polymorphisms have been found that
associate with diverse phenotypes and disease (see Table 1).
One PER3 polymorphism (rs57875989) of particular interest is
the coding-region (exon 18) variable number tandem repeat3 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
Fig. 2. PER3 gene expression in different mouse and human tissues. A) Mouse data from 12 different tissues measured in constant darkness (previous light/dark cycle indicated)
across 48h were extracted from CircaDB (http://circadb.hogeneschlab.org/). The data were Z-scored prior to plotting. B) Human blood expression data were taken fromM€oller-Levet
et al., 2013 and Archer et al., 2014, GEO accession numbers: GSE39445 and GSE48113. Z-scored average PER3 mRNA abundance values (across multiple probes and participants)
were calculated for each sampling point in each of the four conditions assessed (sleeping in phase with melatonin [light blue], sleeping out of phase with melatonin [dark blue],
during total sleep deprivation after one week of sufﬁcient sleep [light green], and total sleep deprivation after one week of insufﬁcient sleep [dark green]). Each sampling point was
assigned the average relative clock time of that sample, as indexed by the dim light melatonin onset (DLMO ¼ 0, approximately 10pm). In the protocol of M€oller-Levet et al., 2013,
three samples prior to DLMO were collected whereas in Archer et al., 2014, only one sample prior to DLMO was collected. To readily compare the data between protocols, the
double-plotted data shown are the time series from one sampling point prior to DLMO to 24h. Average melatonin curves for the sleeping in phase (light blue) and sufﬁcient sleep
(light green) conditions are shown. C) Z-scored PER3 mRNA abundance values from human post-mortem data obtained from the processed GEO data set GSE71620 (Chen et al.,
2016). A cubic smoothing spline was ﬁtted to the data (5 knots, smooth.spline function in R) and the ﬁtted data are double plotted. Data are shown from two brain areas;
Brodmann's area 11 (dark grey) and area 47 (light grey). Relative clock time refers to hours after the onset of a pseudoday (¼ 0; see Chen et al., 2016).
S.N. Archer et al. / Sleep Medicine Reviews xxx (2017) 1e184(VNTR). The 18-amino-acid tandemmotif is repeated 4 or 5 times in
humans such that individuals are homozygous (PER34/4 [~45%] or
PER35/5 [~10%]) or heterozygous (PER34/5 [~45%]) for the two alleles.
PER3 is phosphorylated by CK1 and translocates to the nucleus to
inhibit CLOCK/BMAL1 in the presence of PER1 [34]. The VNTRmotif
contains clusters of potential phosphorylation sites for CK1 [35].
Post-translational modiﬁcation by CK1 affects the stability and
nuclear translocation of PER [36]. Mutation in a single CK1Please cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10phosphorylation site in PER2 is associated with shortened circadian
period and advanced sleepewake timing in familial advanced sleep
phase disorder (ASPD) [37,38]. Thus, the presence of 4 or 5 repeats
in PER3 could change overall protein phosphorylation levels by
~20% [35] and could also signiﬁcantly change protein tertiary
structure, with implications for the way in which PER3 interacts
with other core clock proteins in the multi-globular repressor
complex [2].3 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
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The PER3 VNTR
Because the PER3 VNTR could change protein phosphorylation
levels in addition to tertiary protein structure and interactions with
binding partners, this led to the hypothesis that the VNTR would
cause functional changes in PER3 that would be associated with
measurable individual phenotypic differences [35]. This hypothesis
was validated through the association of the 5-repeat allele with
morning diurnal preference and its lower than expected frequency
within patients suffering from delayed sleep phase disorder (DSPD)
[35]. The PER3 VNTR appears to be primate-speciﬁc [39] and it has
been speculated that the expansion of the VNTR region enabled
Simiiforme primates to adapt to a diurnal niche [40].
The association between PER3 and diurnal preference has since
been replicated in several studies [41e44], including a large study
population of 675 individuals [45]. The latter study did not select
participants according to extreme chronotype and only investi-
gated the effects of the PER3 VNTR, thereby avoiding the risk of
false positive ﬁndings. While observed diurnal preference differ-
ences between the genotypes weremodest in that study (e.g., mean
[±SD] diurnal preference scores of 51.06 ± 7.89 vs. 53.31 ± 7.90 for
PER34/4 and PER35/5, respectively), they were statistically signiﬁcant
(P < 0.05; Fig. 3). In addition to the predicted diurnal preference
difference, Lazar et al. also found associations between the PER35/5
genotype and earlier sleep onset (PER35/5 15min earlier than PER34/
4), mid sleep (PER35/5 17 min earlier than PER34/4) and wake timing
(PER35/5 22 min earlier than PER34/5) (Fig. 3). PER35/5 also showed
lower daytime sleepiness and a larger increase in time in bed on
rest days compared to other genotypes. It should be noted that, in
accordance with the effects of other polymorphisms, the effect
sizes were small (i.e., SD is in general 4 times larger than the dif-
ference in themeans). Furthermore, Lazar et al. reported interesting
genotype-dependent phenotype interactions. PER35/5 individuals
with a delayed mid sleep time on workdays had a signiﬁcantly
higher body mass index (BMI) compared with the other genotypes,
and PER35/5 individuals who slept >9 h during workdays performed
worse on a ﬂuid intelligence test compared with the other geno-
types [45]. These interactions between genotype and other risk
factors on outcome measures are similar to more recent reports on
the interaction between diurnal preference, BMI and a poly-
morphism in the circadian gene CLOCK [46]. The study by Liberman
et al. also found the 4-repeat allele to be more frequent in evening
types, and the PER34/4 and PER35/5 genotypes less frequent in
morning types and in evening types, respectively [44]. Of interest,
Liberman et al. also used a complex circadian clockmodel to predict
that decreased and increased phosphorylation levels associated
with the PER34/4 and PER35/5 genotypes, respectively, would lead to
a lengthened (24.5 h) and shortened (22.8 h) period length in those
genotypes, which agrees well with the associated diurnal prefer-
ence and DSPD phenotypes [44].
Other PER3 polymorphisms
The involvement of PER3 in determining diurnal preference and
its contribution to CRSWDs is further supported by associations
with other polymorphisms within PER3. Within the PER3 promoter
region, three SNPs (rs2797687, G/T; rs2794664, C/A; rs228730, G/A)
and a VNTR polymorphism consisting of one or two copies of a
tandem 21-nucleotide repeat have been identiﬁed and are associ-
ated with diurnal preference and DSPD [47]. A speciﬁc haplotype
(TA2G) of the promoter polymorphisms was more prevalent in
DSPD and also increased gene expression levels when the PER3
promoter containing that haplotypewas used to drive expression ofPlease cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10a reporter gene construct, comparedwith constructs containing the
other promoter haplotypes.
Within the PER3 coding region, a speciﬁc haplotype of four
missense single nucleotide polymorphisms (SNPs; rs10462020,
rs228697, rs2640909, rs10462021) and the VNTR was found to be
more prevalent in DSPD patients [32]. One of the SNPs
(rs10462020) is close to the conserved phosphorylation sites in
PER2 affected by the mutation linked with ASPD [37] and the same
SNP was also linked with morning preference in a separate study
[48]. Another of the DSPD haplotype SNPs (rs2640909) has also
been linked with morning preference [49], while the minor allele
(G) of a third (rs228697) was linked with evening preference
[44,50], circadian free-running types [50], and depression [51] (see
below). Interestingly, a recent study has found the opposite asso-
ciationwith the G allele of rs228697 being associated withmorning
preference, and a haplotype containing the G allele and the VNTR 4-
repeat also associated with morning preference [52]. In addition,
homozygotes for the VNTR 4-repeat allele had an advanced urinary
6-sulfatoxymelatonin acrophase [52]. The rs228697-G/VNTR-4-
repeat haplotype was also associated with worse mood in the
evening, and carriers of the G allele had earlier wake times, less
sleep and poorer sleep quality [52]. However, this recent study also
reported reduced sleepiness in the PER35/5 in the morning
compared to the other genotypes [52], which does agree with
ﬁndings from Lazar et al. [45].
Replication failures
As the above studies indicate, the association between PER3
genotype and diurnal preference or sleep phenotypes has not al-
ways been replicated. This may be due to a combination of factors
such as different study populations and phenotyping tools (e.g.,
[53e56]). However, an alternative hypothesis in which interactions
between social constraints, genotype and phenotypes are taken
into account is worth considering. For example, it has been shown
that some categories of athletes have a higher tendency to be
morning types compared to controls, which has been related to a
greater prevalence of competition and practice schedules in
morning periods [43,56]. It has also been shown that individual
sport endurance athletes (cycling, running, ironman) had a higher
frequency of the PER35/5 genotype and morning preference
compared to controls [43]. However, in a recent study, team rugby
players were found to have increased morning preference
compared to controls. Whereas as expected in the controls PER3
genotype associated with morning preference, there was no as-
sociation with PER3 genotype in the rugby players [57]. The au-
thors hypothesise that preference in rugby players is determined
largely by social constraints of habitual morning athletic behaviour
and not by genotype. This highlights the complexities in deter-
mining the role of gene variants in behaviour based on phenotype
assessment tools that can also be confounded by social factors.
Evidence from GWAS studies
While candidate gene approaches that have speciﬁcally targeted
PER3 have undoubtedly been successful, recent large-scale
genome-wide association studies (GWAS) have also highlighted
PER3. A study of more than 89,000 individuals found an association
between diurnal preference and a SNP variant (rs11121022) close to
PER3 [58]. However, rs11121022 actually lies within the adjacent
VAMP3 gene meaning that PER3 may not be causative in this as-
sociation. Another GWAS in more than 100,000 individuals found a
suggestive signal (rs7545893) for diurnal preference close to the
PER3 VNTR [59]. Several SNPs in PER3 (but not the VNTR) were
associated with phenotypes associated with sleep (rs228642 with3 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
Table 1
Variant identiﬁcation and information. The Global MAF refers to the minor allele frequency obtained from the 1000 Genomes Project Phase 3. Variants are listed according to
chromosome position (50 to 30 of gene). Affected amino acids are indicated together with their position. Associated phenotypes are listed.
Variant Position (Chr1) Alleles Global MAF Class Type Amino Acid AA Position Phenotype References
rs11121022 1:7776599 A/C 0.304 (C) SNP Intronic Diurnal preference [58]
rs2797687 1:7784383 G/T 0.298 (T) SNP Promoter Diurnal preference, DSPD [47]
rs2794664 1:7784384 C/A 0.298 (A) SNP Promoter Diurnal preference, DSPD [47]
b 1:7784385e7784405 1/2VNTR 0.010 (1) Indel Promoter DSPD [47]
rs228730 1:7784409 G/A 0.062 (A) SNP Promoter DSPD [47]
rs228729 1:7785635 T/C 0.276 (T) SNP Intronic Bipolar disorder, lung cancer,
gastric cancer, hepatic cancer
[94,117e119]
rs836755 1:7786467 A/C 0.442 (C) SNP Intronic Bipolar disorder, sleep onset [96]
rs11579477 1:7786940 A/G 0.005 (G) SNP Intronic EEG delta power [60]
rs7545893 1:7796207 C/A 0.120 (A) SNP Intronic Diurnal preference [59]
rs228682 1:7796286 T/C 0.311 (C) SNP Intronic Depression [91]
rs1012477 1:7798075 G/C 0.116 (C) SNP Intronic Diurnal preference, prostate
cancer, breast cancer
[60,115,116]
rs228642 1:7803233 C/T 0.416 (T) SNP Intronic Bipolar disorder, sleep duration [60,94]
rs228644 1:7806023 G/A 0.308 (A) SNP Intronic Depression [91]
rs228666 1:7808665 T/C 0.310 (C) SNP Intronic Bipolar disorder [94]
rs150812083 1:7809893 C/G 0.003 (G) SNP missense Coding P/A 414 ASPD, PER3 stability, circadian
period, SAD
[89]
rs139315125 1:7809900 A/G 0.003 (G) SNP missense Coding H/R 416 ASPD, PER3 stability, circadian
period, SAD
[89]
rs228669 1:7809988 T/C 0.121 (T) SNP synonymous Coding S 445 Hepatic cancer [119]
rs12137927 1:7811169 T/C 0.183 (C) SNP Intronic Depression [91]
rs2172563 1:7813983 G/A 0.183 (A) SNP Intronic Bipolar disorder [96]
rs10462020 1:7820623 T/G 0.121 (G) SNP missense Coding V/G 639 Diurnal preference, DSPD, B cell
lymphoma
[32,48,120]
rs2859387 1:7827188 G/A 0.483 (G) SNP synonymous Coding P 745 Bipolar disorder, schizophrenia [92]




rs17031614 1:7827545 A/G 0.094 (A) SNP synonymous Coding S 872 Depression [51]
rs2859388 1:7828155 A/G 0.472 (A) SNP Intronic Bipolar disorder [94]
rs57875989 1:7829993e7830046 4/5VNTR 0.317 (5)c Indel Coding ALSTGSPPM
KNPSHPTAS












rs2640909 1:7830057 T/C 0.185 (C) SNP missense Coding M/T 1028 Diurnal preference, DSPD [32,49,119]
rs10462021 1:7837073 A/G 0.121 (G) SNP missense Coding H/R 1158 DSPD [32]
ASPD, advanced sleep phase disorder; DSPD, delayed sleep phase disorder; EEG, electroencephalogram; fMRI, functional magnetic resonance imaging; Indel, insertion or
deletion; PER3, Period3; SAD, seasonal affective disorder; SNP, single nucleotide polymorphism; VNTR, variable number tandem repeat.
a rs228697 P/A is variously referred to amino acid 864 or 856 in different publications and databases.
b The promoter 1/2VNTR has not been assigned a variant identiﬁcation (minor allele frequency was taken from Archer et al. [47]).
c Minor allele frequency for UK taken from Nadkarni et al., 2005 [128].
S.N. Archer et al. / Sleep Medicine Reviews xxx (2017) 1e186total sleep time; rs11579477 with electroencephalogram [EEG]
delta power) and chronotype (rs1012477) in patients with late-life
insomnia [60]. These non-targeted GWAS studies add further sup-
port for the role of PER3 in a diverse range of phenotypes.
Underlying mechanisms linking PER3 genotype with function
The studies by Hida et al. and Turco et al. both speculated that
the proline to alanine substitution associated with rs228697
could disrupt Src homology 3 binding domains that could disrupt
the interaction of PER3 with other clock proteins and lead to the
observed associations with diurnal preference, albeit opposite
ones in each study [50,52]. Shi et al. who reported an association
between rs228697 with depression, went further and showed
that the proline to alanine substitution stabilized PER3 and
increased its recruitment of PER2 to the repressor complex,
leading to stronger repression of CLOCK/BMAL1. Expression of the
alanine variant in ﬁbroblasts also increased the period length of
gene expression of a reporter construct [51], which would ﬁt with
an evening preference phenotype and its link to depression in
adults [61]. Both Hida et al. and Turco et al. point out that thePlease cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10proline to alanine substitution will alter the hydropathy index at
that amino acid site which could change the local secondary
structure of the protein and potentially affect its interaction with
CK1 and phosphorylation levels of the protein. Related to this, it
should be noted that a hydrophobicity plot of the entire human
PER3 exon 18 containing the VNTR shows very distinct alter-
nating hydrophobic/hydrophilic domains that correspond to the
VNTR repeat domains (Fig. 4). Such a regular structure could
predict a series of externally facing loops in the PER3 protein in
this region, presenting phosphorylation sites for CK1 with
obvious implications for phosphorylation levels associated with
either 4 or 5 such loop structures. Structural differences in the
PER3 protein due to the VNTR in exon 18 are perhaps now even
more relevant given the recent demonstration of the close
interaction of PER3 with the other PERs, CRYs and CK1 in a
globular protein repressor complex [2].
PER3 VNTR and sleep homeostasis
In the ﬁrst electroencephalogram (EEG) sleep study comparing
14 PER34/4 vs. 10 PER35/5 participants in their twenties, several sleep3 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
Fig. 3. The effect of the PER3 VNTR on diurnal preference and sleepewake schedules. A) Morningness eveningness questionnaire (MEQ) diurnal preference scores (mean ± sem) in
663 individuals by genotype and sex. Diurnal preference score was higher (more morning preference) in PER35/5 compared with PER34/5 (p ¼ 0.001) and PER34/4 (p ¼ 0.033). There
was no sex difference. B) MEQ scores (mean ± sem) for each PER3 genotype in 663 individuals divided into three age groups each representing roughly one third of the study
population. Diurnal preference was different between genotypes (F2,658 ¼ 5.45, p ¼ 0.005) and increased with age (F2,658 ¼ 15.28, p < 0.001). C) Effect of PER3 VNTR on bedtime,
midpoint of sleep and wakeup time as derived from averages (mean ± sem) of data collected from multiple questionnaires (see Lazar et al., 2012). Time in bed is indicated by
horizontal bars. Signiﬁcant differences between genotypes are indicated by horizontal lines (*p < 0.05, **p < 0.01, ***p < 0.001). Figures adapted from Lazar et al. [45].
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following sleep deprivation (SD) [62]. At baseline, PER35/5 in-
dividuals fell asleep quicker and had more slow wave sleep (SWS)
than PER34/4 individuals. Rapid eye movement (REM) sleep and
total sleep time did not differ between the genotypes. Quantitative
analyses of the EEG revealed more slow wave activity (SWA) in
PER35/5 in the initial part of both baseline and recovery sleep, while
SWA did not differ between genotypes in the latter part of the
night. During REM sleep, alpha activity was enhanced in PER35/5,
whereas during wakefulness, EEG theta activity was higher in the
PER35/5 individuals. Since SWS, SWA and theta activity in wake-
fulness are all considered markers of the sleep homeostat, these
data are in accordance with the hypothesis that PER35/5 individuals
live under a higher homeostatic sleep pressure [63].
A ﬁrst attempt to replicate effects of the VNTR on sleep and
cognition included 52 PER34/4, 63 PER34/5 and 14 PER35/5 young
adults [53]. At baseline, subjective sleepiness measures varied
signiﬁcantly across the three genotypes and in the maintenance of
wakefulness test. The heterozygous participants were most sleepy,
followed by the PER35/5 participants. At baseline, no differences
were observed in sleep structure across the three genotypes, except
for a tendency for sleep latency (p < 0.1), with the PER35/5 dis-
playing the shortest sleep latencies. During ﬁve consecutive nights
of partial sleep deprivation (PSD; 4 h time in bed), slow wave en-
ergy (SWE), expressed as a percentage of the values at baseline,
varied signiﬁcantly across the three genotypes such that the PER35/5Please cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10participants had a signiﬁcantly stronger SWE response to PSD than
the two other genotypes. Higher relative SWAvalues in the ﬁrst non
rapid eye movement (NREM) episode in PER35/5 participants were
also observed during baseline sleep in another study [16].
PER3 VNTR, sleep and ageing
Whereas the previous studies were conducted in young adults, a
study conducted in 26 older participants (13 of each homozygous
genotype) [64] found that, at baseline, PER35/5 participants were
less sleepy during daytime. At baseline, sleep efﬁciency was
signiﬁcantly lower in the PER35/5 participants and this was pri-
marily related to more wakefulness in the second part of the night.
Visually-assessed sleep structure was not different between geno-
types during either baseline or during recovery sleep following
total sleep deprivation (TSD). Quantitative EEG analyses revealed
higher low frequency EEG activity (0.75e1.5 Hz) in a frontal deri-
vation in NREM sleep in PER35/5 participants. In addition, frontal
sigma activity (11e13 Hz) was reduced.
PER3 VNTR in mice: effects on sleep and gene expression
These human studies all indicate that the PER3 VNTR affects low
frequency EEG activity in NREM sleep either both at baseline and
during recovery sleep from TSD, or in response to PSD. Overall,
these results in humans are consistent with a role of the PER3 VNTR3 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
Fig. 4. Hydrophobicity plot for the human PER3 exon 18 containing the VNTR. The schematic PER3 protein shows the VNTR polymorphic region toward the C-terminal of the
protein (amino acids 965e1054) in relation to binding regions for CK1 and CRY, and the PASA and PASB domains that enable binding to other proteins such as PER, CLOCK and
BMAL1. The amino acid sequence for the ﬁve VNTR units is shown beneath, with the missing third unit indicated for the 4-repeat allele. The entire exon 18 amino acid sequence was
submitted to ExPASy (www.expasy.org) and the Kyte & Doolittle scale was used for amino acid hydropathy scores with an averaging window of 9. Data are displayed from exon 18
amino acids positions 959 to 1060. The VNTR repeat motifs are numbered 1e5. A positive score indicates hydrophobic regions and a negative score, hydrophilic ones.
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number of awakenings have subsequently been observed for a
common variant of the human clock gene PER2 in a carefully
controlled study that included a replication sample [65]. Previously,
several animal studies had demonstrated effects of various clock
genes on sleep homeostasis [66]. Since the PER3 VNTR is primate-
speciﬁc, the role of the PER3 VNTR is not easily investigated inmice.
One approach to overcome this difﬁculty is to insert the PER3 VNTR
in mice. Implementation of this demonstrated several effects of the
human VNTR onwaking EEG and sleep characteristics in mice. EEG
power in the 8.5e11 Hz range in wakefulness during SD was higher
in the Per35/5 mice [67]. Also, during recovery sleep, SWE lost
during SD was fully recovered in Per35/5 mice but not so in Per34/4
mice (Fig. 5). These electrophysiological markers again point to an
effect of the VNTR polymorphism on NREM sleep homeostasis. In
addition, it was found that molecular markers of sleep homeostasis
(e.g., ion channels and neurotransmitter receptors), but not circa-
dian clock genes, were differentially affected by SD across the ge-
notypes (Fig. 5). Microarray analysis showed that probes targeting
Homer1 transcripts were differentially regulated and probes that
target the short Homer1a transcript, which is ﬁrmly linked to sleep
homeostasis [68,69] were up-regulated in Per35/5 mice (Fig. 5).
Furthermore, Ptgs2, which is an activity and SD-induced gene, was
differentially regulated across the genotypes (Fig. 5). Since some of
these genes, and Homer1 in particular, are also strongly implicatedPlease cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10in synaptic plasticity, these data may provide a link between sleep
homeostasis and the cognitive phenotypes found in PER3 VNTR
genotypes.
Effects of PER3 VNTR on cognition depend on cognitive
domain, sleep pressure and circadian phase
Several studies have indicated that PER3 VNTR genotype may
inﬂuence the effects of sleep loss on cognitive function. Young
PER35/5 participants performed signiﬁcantly worse in cognitive
tasks than PER34/4 during SD [62]. This effect was most pronounced
when performance was assessed in the late-night and early-
morning hours, i.e., at a time of high sleep need when the circa-
dian timing system does not promote wakefulness [70]. Because no
differences in core physiological markers of circadian rhythmicity
were found between PER3 genotypes, it was concluded that the
inﬂuence of the PER3 VNTR polymorphism on neurobehavioral
performancewas primarily due to differences in sleep homeostasis,
the negative impact of which is strongest at an adverse circadian
phase. Indeed, the impact of sleep pressure on performance de-
pends on its interactionwith circadian phase such that during sleep
deprivation, the detrimental effect of high homeostatic sleep
pressure is ampliﬁed by the maximal circadian sleep promotion in
the early morning hours to a greater degree in PER35/5 individuals
than in PER34/4 [63].3 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
Fig. 5. A) Time courses for accumulated differences in rapid eye movement sleep (REMS) time, non REMS time, and SWE during SD and subsequent 36 h of recovery after SD.
Accumulated values (mean ± sem) are relative to baseline (horizontal dashed line) for each genotype. For the SWE comparison, genotype effects are indicated for the hourly
intervals (black symbols ¼ Per35/5 higher than Per34/4; grey symbols ¼ Per35/5 higher than WT; red symbols ¼ Per35/5 higher than Per34/4 and WT; *P < 0.05, #P < 0.01. B) Dis-
tribution of normalised change in probe expression levels (log2 fold change) for all probes differentially expressed between Per35/5 and Per34/4 mice after SD in cortex (green curve)
and hypothalamus (blue curve). The percentage of probes that showed signiﬁcant differential expression between genotypes is indicated by bars (green ¼ cortex;
blue ¼ hypothalamus). C) Up- and down-regulated fold change in the expression of core clock genes (top) and sleep regulation-associated genes (bottom) between Per34/4 and
Per35/5 mice in both tissues (black bars ¼ down-regulated in Per35/5 vs. Per34/4; red ¼ up-regulated in Per35/5 vs. Per34/4). Vertical dashed lines (B and C) indicate the maximum fold
change for the clock gene transcripts, all non-signiﬁcant. D) Mean (±sem) normalised expression across both tissues in the 3 genotypes for two probes that target the 50 UTR (left)
and two probes that target the 30 UTR (right) of Homer1. Only the 50 UTR probes target the Homer1a transcript. Figures adapted from Hasan et al., 2014. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.). Abbreviations: REMS - rapid eye movement sleep; SWE - slow wave energy; SD -
sleep deprivation; WT - wild type.
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Genotypic differences in the response to sleep loss were shown
to also depend on cognitive domain [71]. Performance on tests with
a high load on executive function, such as the 3-back workingPlease cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10memory paradigm, deteriorated signiﬁcantly more for PER35/5
participants in the early morning hours. This result was conﬁrmed
in a TSD study following a week of either sufﬁcient or insufﬁcient
sleep (Fig. 6) [72]. However, a partial sleep restriction study failed to
observe genotype-speciﬁc effects for cognitive tests that also3 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
Fig. 6. Effects of PER3 genotypes on the circadian modulation of performance during total sleep deprivation following partial sleep deprivation. A) Verbal 3-back performance
during total sleep deprivation (TSD) in the sleep restriction (ﬁlled symbols) and the control conditions (open circles) separately for the three PER3 genotypes. (DLMO: dashed grey
vertical line and melatonin proﬁle averaged between the two conditions shaded in grey). B) Effect sizes for the genotype  sleep history condition interaction during TSD for
Subjective Alertness, Sustained Attention, and Working Memory, computed for each 4-h circadian melatonin bin. C) Effect size averaged across the six performance measures. Only
small effect sizes are observed (above horizontal line). Error bars represent the between performance measure standard error of the mean. In panels B and C, horizontal lines
indicate cut-offs for small and medium effect sizes (reprinted with permission from [72]).
S.N. Archer et al. / Sleep Medicine Reviews xxx (2017) 1e1810measured executive function [53]. Notably, performance in this
study was averaged across the day and was not assessed at the
sensitive time-window of the early morning hours. In a study
where sleep was restricted to 3 h time in bed for seven nights,
individuals with the combined PER34/4 and the adenosine receptor
ADORA2AC/T genotype were more resilient to detrimental effects of
sleep restriction on performance in a psychomotor vigilance task
(PVT) compared to individuals with the PER34/5 and ADORA2AT/T
genotype [73].Please cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10In the past, it was suggested that SD particularly affects execu-
tive control processes [74]. However, dissociation studies andmeta-
analyses do not support this hypothesis and reveal that non-
executive task components are more affected by SD than execu-
tive ones [72,75,76]. Furthermore, effects of circadian phase on
cognition are also at least as large for alertness and attention tasks
than for working memory tasks with a high executive load [77].
Importantly, however, this does not exclude the possibility that a
trait-like manipulation of sleep homeostatic regulation, as PER33 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
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under conditions of total sleep loss (Fig. 6A), while subjective
alertness and vigilant attention were simultaneously shown to be
largely affected in both genotypes [72]. The effect size of genotypic
effects was, however, lower than the state-induced effects on
alertness and sustained attention. Nevertheless, the observed small
deﬁcits (Fig. 6B) indicate that the top-down executive control of
attention required to engage with a task might be ultimately
affected in a trait-like manner by misalignment between circadian
and homeostatic processes, notably when sleep deprived during
the biological night (Fig. 6C).
PER3 and fMRI studies
In fMRI studies, PER3 genotypewas reported to affect cortical and
subcortical brain activations during the performance of a 3-back
task in the morning after TSD [78]. PER35/5 carriers presented
widespread reductions in task-related cortical activations in the
morning following sleep loss. This occurred after these participants
already presented a reduced prefrontal activation in the evening
before [78]. By contrast, PER34/4 participants showed only increased
activations following sleep loss. These activations were present
notably in the prefrontal cortex and depended on the input received
from the thalamus (increased functional connectivity between
thalamus and prefrontal area). This supports the notion that these
brain areas play a central role in executive control during prolonged
wakefulness [70,78,79]. Task duration was kept short such that the
disparity in brain responses during sleep loss was detected in the
absence of signiﬁcant behavioural changes that could bias neuro-
imaging results. They are therefore likely to precede the previously
reported difference in performance to the same task when it was
included in a more demanding and extensive test battery [62,71].
Effects of PER3 in sleep deprivation versus ultra-short sleepewake
cycle protocols
In contrast to executive function, several studies failed to ﬁnd an
impact of PER3 genetic variants on vigilant attention (PVT)
following TSD [72], partial sleep restriction [53], and partial sleep
restriction with subsequent TSD [72]. Yet, when combining a 40-h
TSD and an ultrashort sleepewake cycle (nap) protocol as a
manipulation of sleep pressure, PER35/5 carriers produced signiﬁ-
cantly more lapses than PER34/4 participants under sleep loss, when
compared to the multiple nap condition [80]. The approach applied
by Maire et al. is effective in isolating homeostatic state effects,
since it allows a comparison of rising (sleep deprivation) versus low
(multiple naps) homeostatic levels while controlling for circadian
phase. Similarly, PER35/5 carriers had more difﬁculties to maintain
stable attentional performance over the 10-min PVT than PER34/4
carriers during night-time under high sleep pressure conditions
[81]. These data suggest that PER35/5 individuals are more prone to
momentary task disengagement during wakefulness when sleep
need is high and particularly so during the biological night. In
accordance with this hypothesis, Maire et al. observed that, during
night-time, thalamic activity progressively diminished with time-
on-task in PER35/5 individuals, which were also more susceptible
to activate structures associated with the default mode network
during disengagement [82]. Maire et al. also revealed that PER35/5
individuals produced signiﬁcantly more slow eye movements and
unintentional sleep episodes under SD than the PER34/4 individuals,
especially during the biological night and in the beginning of the
second biological day [80]. Furthermore, already in the ﬁrst SD
study [62], PER35/5 had higher levels of EEG theta activity, which is
considered a marker of sleepiness, correlates negatively with task
performance and may be a sign of disengagement.Please cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10PER3 and age-related changes in cognition and brain structure
Finally, a recent study assessed the effects of the PER3 VNTR
polymorphism on age-related changes in cognition, brain struc-
ture and metabolism [83]. It was observed that reduced cognitive
performance (semantic memory, cognitive interference and ver-
bal ﬂuency) in older PER35/5 carriers co-occurred with reduced
structural and functional integrity at the cortical level and also
with reductions of glucose consumption in fronto-temporo-
parietal regions. Amongst others, reduced cortical thickness
entailed the entorhinal cortex and lower relative metabolism was
detected in the middle temporal lobe [83], both regions being of
key relevance for cognitive ageing and associated declines in
memory function [84].
Human behaviours are thus endangered by sleep loss, depend-
ing on when it occurs over the 24-h cycle, which cognitive
component is assessed, but also the genetic background of the in-
dividual (see Fig. 7A for schematic overview). The brain mecha-
nisms underlying differential vulnerability to sleep state
manipulation remain to be further explored, but may involve
thalamic and frontal cortex responsiveness (Fig. 7B). A recent study
revealed that both thalamic and cortical responses underlying
vigilant attention exhibit circadian rhythmicity [85]. The manifes-
tation of the interaction between sleep need and circadian phase
was, however, brain region and task speciﬁc. One could speculate
then that inter-individual variability in response to sleep loss would
reside in trait-like differences in brain local rhythmicity rather than
in the ability or inability to recruit a given brain process.
Genetic variation in PER3 modulates the impact of light
Exposure to light is the main synchroniser of human circadian
rhythms [70]. In humans, light also conveys a stimulating signal
that acutely increases alertness, improves some aspects of cognitive
performance, and modulates cognitive brain responses during
wakefulness and affects subsequent sleep intensity [70]. Animal
and human experiments have shown that these effects are most
likely mediated through a pathway involving intrinsically photo-
sensitive retinal ganglion cells (ipRGC) expressing the blue-light-
sensitive melanopsin photopigment, in addition to input from
rods and cones [86].
PER3, light and sleep/performance
The PER3 VNTR has been used to investigate inter-individual
differences in effects of light on cognition and physiology. Sup-
pression of melatonin and reductions in subjective and objective
EEG measures of sleepiness in response to 2 h of evening exposure
to blue-enriched light were more pronounced in PER35/5 vs. PER34/4
individuals [15]. Intensity of subsequent sleep, as indexed through
EEG SWA, was also reduced over the occipital derivations in PER35/5,
but not in PER34/4 carriers [15]. This reduction in the visual occipital
cortex could putatively represent a use-dependent effect as PER35/5
also perceived blue-enriched light as brighter than PER34/4 [15]. All
these data suggest that the PER35/5 genotype confers increased light
sensitivity in humans. In animal studies, a reduced masking effect
of light was observed in PER3-deﬁcient mice during the rest
phase (light) but not the active phase (dark) of the circadian cycle
[14,87].
PER3 VNTR, light and fMRI studies
A neuroimaging study revealed that brain responses to an
auditory working memory task increased in response to short
(1 min) exposure to blue light in the morning hours following a3 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
Fig. 7. Putative scenario of the impact of sleepewake manipulation and the PER3 VNTR polymorphism on human cognition. A) Impact of sleep homeostatic challenge (partial vs.
acute sleep loss) according to cognitive domain (subjectively assessed alertness, vigilant attention as assessed by a psychomotor vigilance task and executive function as assessed by
the N-back paradigm). Independent of genotype the impact of sleep loss on behaviour is most pronounced for alertness and vigilant attention. Black bars schematically represent
effect sizes as reported in Lo et al. (2012). The PER3 polymorphism modulates subjective alertness under partial sleep loss and alertness and executive function during acute sleep
loss (balances on the right side; n.s. ¼ not signiﬁcantly different between the genotypes in the study that tested the hypothesis). State instability as assessed by momentary task
disengagement or time-on-task might reﬂect executive control in attentional tasks (attention-executive) and thereby represent a potential tool to explore both state and trait effects
on performance (Maire et al., 2014 [80], 2015 [82]). Finally, light has been shown to modulate the genotype-dependent impact on executive brain function following acute sleep loss
(green star; Vandewalle et al., 2011). B) The PER3 VNTR polymorphism affects task-related activation in thalamic, prefontal as well as in midline regions encompassing the default
mode network (DMN). Under sleep loss, PER35/5 individuals show decreased prefrontal and thalamic activity during task engagement (Vandewalle et al., 2009 [78]) and activity
increases in key regions of the default mode network during momentary task disengagement (Maire et al., 2015). By contrast, PER34/4 show increased thalamic and prefrontal
activation following acute sleep loss. The thalamus (THA) seems to play a central role in mediating the impact of high sleep pressure on cognition, particularly via its connections
with the prefrontal cortex (blue-red dots). Light can impact on the cortical circuitry underlying task performance, putatively via subcortical and thalamic connexions. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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[16]. This implies that the PER35/5 individuals who were previously
shown to present widespread decreased brain activation while
performing the sameworkingmemory task [78], beneﬁt more from
light exposure. In the morning hours following a normal night of
sleep, an impact of blue light on cognitive brain responses was
detected in PER34/4 individuals and not in PER35/5 [16]. Task and
light exposure durations were again kept short, so distinct light-
dependent brain responses were observed without concomitant
signiﬁcant performance differences. The PER3 genotype-dependent
brain responses under blue light exposure are presumably occur-
ring prior to emerging behavioural differences, but this remains to
be formally tested.
This genotype-dependent impact of light on cognitive brain
activity may reside in the differential association of PER3 genotypePlease cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10with diurnal preference [35] with light beneﬁting relatively more
those who are more inclined to be evening types (i.e., the PER34/4).
No impact of light on cognitive brain responses was detected in the
evening hours, close to melatonin secretion onset, in either geno-
type [16]. This may appear contradictory with the fact that evening
light can suppress melatonin and affect sleepiness in the evening,
particularly so in PER35/5 [15]. However, as compared to PER34/4,
PER35/5 individuals could still be more inﬂuenced by a 2 h exposure
to blue-enriched light [15], while neither genotype showed a sig-
niﬁcant impact of 1 min blue light exposures [16]. Likewise, both
genotypes may be less affected by light in the evening as compared
to other circadian times both using 1 min [16] or 2 h exposures, but
such longer exposure durations have not yet been tested at
different circadian phases. We infer that, around the evening wake
maintenance zone, alertness is already most affected by the3 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
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external stimulant such as light would be less potent. Overall, the
acute impact of light on cognition and physiology seems to depend
on sleep need, circadian phase and PER3 VNTR genotype.
PER3 and light-dependent phenotypes in mice and humans
Per3 KO mice show normal entrainment to the lightedark cycle
as well as normal phase delays or advances to a single pulse of
light [14]. A slower re-entrainment to a shifted lightedark cycle
[14] and to abrupt changes in photoperiod [87] were reported in
Per3 KO mice. Decrease in circadian period lengthening under
constant light conditions, as well as poor entrainment to a
3.5 he3.5 h ultradian lightedark cycle were also reported in Per3
KO mice [14]. Animal data suggest therefore that the long-term
impact of light on circadian rhythmicity seems to be Per3
genotype-dependent, likely through a decreased sensitivity to
light in the absence of the Per3 gene. The long-term circadian
impact of light has not yet been considered in humans with
respect to PER3 VNTR. Given that the genotype inﬂuences mela-
tonin suppression by light [15] and that the impact of light on
circadian phase is inﬂuenced by sleep need [88], it is likely that
the human PER3 VNTR also affects the way light entrains and/or
phase shifts circadian rhythmicity. Because PER3 is expressed in
light-sensitive tissues (cf. above), its polymorphisms could affect
light sensitivity per se, but could also determine how much beneﬁt
light can bring with respect to current sleep need and circadian
phase status. Whether and how the genotype-dependent light
effects may relate to the association of PER3 VNTR genotype with
diurnal preference remains to be established.
Further evidence for a role of PER3 in determining the response
to light stems from two rare human missense variants in PER3
(P415A, rs150812083; H417R, rs139315125) which have been
associated with ASPD [89]. The variants destabilise PER3 and
reduce its ability to stabilise PER1 and PER2, leading to reduced
repression of CLOCK/BMAL1-driven Per2 expression (Fig. 1) [89].
When the combined variants were expressed in mice, onset of lo-
comotor activity was delayed on a 4:20 h light:dark cycle, and a
longer circadian period in constant light conditions was observed
[89]. Although this is in contrast to the shorter period seen in Per3
KO mice under the same conditions [14], both studies point toward
altered light-sensing phenotypes in these different Per3 models.
Thus, although the PER3 VNTR was initially thought to not signif-
icantly affect circadian parameters, these data suggest that PER3
variants may interact with the light environment to create circa-
dian phenotypes, including sleep timing phenotypes. Indeed, the
PER35/5 genotype was reported to be associated with an advanced
melatonin phase in older volunteers [64].
PER3 and mental disorders and their symptoms
In this section, we will discuss papers that have investigated
associations between PER3 and mental disorders, or symptoms
indicative of mental disorders. Many of the data were collected
prior to the publication of the Diagnostic and Statistical Manual of
Mental Disorders ﬁfth edition (DSM-V; 2013), and therefore use the
term ‘mood disorder’, even though in DSM-V mood disorders are
separated into ‘depressive and related disorders’ and ‘bipolar and
related disorders’. Wherever possible we have adopted the DSM-V
terminology.
Circadian alterations are thought to contribute to depressive
disorders such as seasonal affective disorder (SAD) as well as other
mental disorders [90]. This may explain why genetic variation in
PER3 is associated with depressive disorders and symptoms
[91,51,92], schizophrenia [93] and bipolar disorder [92e97].Please cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10Depressive and bipolar disorders, and schizophrenia
Three intronic PER3 SNPs (rs12137927, rs228644, rs228682)
have been associated with decreased reporting of depressive
symptoms in older male and female adults [91]. A synonymous
(rs17031614) and a missense (rs228697) SNP were associated with
major depressive disorder in males and females, with the DSPD-
associated rs228697 also being signiﬁcant in a female-only subset
[51]. A PER3 SNP (rs2859387) was associated with bipolar disorder
and schizophrenia [93], while a haplotype of 5 SNPs (4 intronic,
rs228729, rs228642, rs228666, rs2859388; 1 non-synonymous,
rs228697) and the exon 18 VNTR showed suggestive links with
bipolar disorder [95]. Epistatic interaction effects have been found
between a PER3 SNP (rs2172563) and two BMAL1 SNPs in bipolar
disorder, and also between a PER3 SNP (rs836755) and difﬁculties
to fall asleep in those patients [92]. The PER35/5 genotype has been
associated with bipolar disorder [96] and earlier onset age for the
disease [94], as well as a poorer response to antidepressant treat-
ment after SD and an increased sleep duration during recovery after
treatment and SD [97].
PER3, light and depressive disorders
The familial cases of ASPD associated with two rare PER3 SNPs
(rs150812083, rs139315125), which also led to circadian pheno-
types in mouse models, were also suffering from SAD and mild to
moderate depression [89]. Furthermore, Per3 KO mice show
alteration in the responses to repeated exposure to dim light at
night (dLAN) i.e., extension of low light levels into the biological
night [98]. dLAN exposure is increasingly common and is thought
to induce a depressive like state through alteration of circadian
rhythmicity in humans [99]. While Per3 KO mice undergo the
typical alterations in cortisol secretion and brain derived neuro-
trophic factor (BDNF) gene expression over the course of the ﬁrst
few weeks of exposure, they show transient abnormal alteration
in mood and activity onset/offset during the ﬁrst weeks of dLAN.
This transient phenomenon may not be causally related to the
longer term dLAN-induced mood alteration, but may be one of
the determining factors for the reported link between PER3
polymorphisms and depression prevalence in humans.
PER3, bipolar disorders and brain structure
Diffusion tensor imaging studies have been used to measure
mean diffusivity (MD), radial diffusivity (RD) and fractional
anisotropy (FA) in white matter (WM) ﬁbres and tracts, and these
measures relate to myelination and axon structure. The technique
was used to study WM in bipolar disorder patients genotyped for
clock gene polymorphisms [100]. The study found that PER34/4 had
increased RD and reduced FA inWM tracts compared to PER35/5 and
indicates that PER3 genotype may inﬂuence brain axonmyelination
[100], which potentially could be related to reported differences in
sleep EEG power spectra.
PER3, addiction and anxiety symptoms
The PER3 VNTR 4-repeat allele has been linked with heroin
dependence in a Chinese population [101], and PER34/4 homozy-
gotes have been reported to suffer more severe insomnia in
alcohol-dependent patients compared with controls [102]. A study
in mice has shown that polymorphisms in Per3 and expression
levels of Per3 are associated with differences in expression of genes
related to schizophrenia, and to alcohol and stress responses [103].
Per3 expression levels correlated with anxiety and addiction phe-
notypes, and alcohol treatment increased expression levels of Per33 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
Practice points
Per3 is one of the most robustly rhythmic genes in a wide
range of tissues in animals and also in tissues investigated
in humans.
Outside of the SCN, PER3 plays a significant role in deter-
mining circadian period and phase.
Polymorphisms within PER3 (especially the primate-
specific VNTR) have been associated with diurnal prefer-
ence, sleep homeostasis, cognition, light sensitivity, axonal
structure, CRSWDs, mental health disorders, and cancer.
In addition, although not covered here, there are very recent
data suggesting that PER3 may also have a role to play in
metabolic functions with links to obesity (e.g., [127]).
PER3 genotype can therefore act as a predictive biomarker
for a wide range of phenotypes and disease conditions.
S.N. Archer et al. / Sleep Medicine Reviews xxx (2017) 1e1814in the hippocampus [103]. Polymorphisms within PER3 have also
been linked with anxiety in humans. Liberman et al. showed that
the carriers of the rs228697 G allele and the VNTR 4-repeat allele
had higher levels of anxiety and that evening types, which associ-
ated with both alleles, were more anxious than morning types [44].
The PER3 VNTR has also been shown to interact with sleep duration
for an association with anxiety in women such that PER34/4 in-
dividuals with short sleep duration were at greater risk of anxiety
and mood disturbance [104].
PER3 and cancer
The cell cycle controls cell division and proliferation. Uncon-
trolled cell proliferation can lead to cancer. The cell cycle is regu-
lated by the interaction of cyclins with cyclin-dependent kinases
and phosphatases and these complexes act as checkpoints for
different steps of the cycle. The circadian clock and the cell cycle are
coupled such that the expression and post-translational modiﬁca-
tion of many elements at different points in the cell cycle are
regulated by the molecular clock. The circadian transcription factor
heterodimer CLOCK/BMAL1 activates expression of the kinase
WEE1, which gates transition from growth phase 2 to mitosis.
CLOCK/BMAL1 inhibits the expression of MYC, which gates transi-
tions from quiescent stage to growth phase and then to DNA
replication. Because of this tight coupling, it is possible that
disruption to circadian rhythms could impact on the development
and progression of cancer, and that circadian rhythms could
become disrupted during cancer (for review, see [105]).
PER3 expression in cancer
Expression levels of PER3 are altered in a range of cancers. In
colorectal cancer, the expression of the negative regulators PER1
and PER3 have been found to be down-regulated, while expression
of the positive regulators CLOCK and BMAL1 was up-regulated
[106]. Decreased expression of PER2 and PER3 was linked with
more aggressive colorectal tumours and worse prognosis [107].
Overexpression of PER3 was found to reduce chemoresistance and
tumour renewal ability in colorectal cancer cells [108]. PER3
expression levels were also reduced in colon cancer compared with
normal tissue, and patients with PER3-negative tumours had
reduced survival times [109]. In addition, PER3 was found to be
downregulated in colorectal cancer while miR-103, which is
increased in many cancers, was upregulated in the same cells and
shown to suppress PER3 expression [110]. By contrast, over-
expression of PER3 repressed tumour proliferation and invasion via
regulation of cell cycle genes. Likewise, the expression of PER3 was
downregulated in acute lymphoid leukaemia and recovery of PER3
expression was associated with better clinical outcome [111]. In
squamous cell carcinoma, downregulated PER3 expression corre-
lated with more advanced cancer stages and larger, more invasive
tumours [112]. Similarly, PER3 expression was reduced in non-
small cell lung cancer and reduced expression was associated
with shorter survival times [113]. Finally, higher expression levels
of PER3 were found to correlate with increased metastasis-free
survival times and improved prognosis in patients with breast
cancer [114]. Together, these data show that down-regulation of
PER3 is associated with poor cancer outcomes, while over-
expression of PER3 contributes favourable outcomes.
Polymorphisms within PER3 can potentially affect its expression
levels and function. Therefore, it should be expected that PER3
polymorphisms are associated with cancer phenotypes and out-
comes. An intronic SNP (rs1012477) in PER3 was associated with
reduced risk of aggressiveness in prostate cancer [115] and also a
reduced risk of breast cancer in women performing threePlease cite this article in press as: Archer SN, et al., Phenotyping of PER
regulation, and health, Sleep Medicine Reviews (2017), https://doi.org/10consecutive nights of shift work [116]. Another intronic PER3 SNP
(rs228729), which was also linked with bipolar disorder, has been
identiﬁed as a risk factor for non-small cell lung cancer [117] and
was associated with overall survival rates in gastric cancer [118]
and hepatocellular carcinoma patients, where the SNP also pre-
dicted recurrence-free survival [119]. The latter study also showed
an association between two additional SNPs (rs2640908, rs228669)
with overall survival rates for the cancer. The PER3 coding-region
missense SNP V647G (rs10462020) that was associated with
DSPD and hypothesised to affect phosphorylation of PER3 by CK1
[32], was associated with increased overall survival in large B-cell
lymphoma [120]. The 5-repeat allele of the PER3 VNTR poly-
morphism (rs57875989) was associated with increased incidence
of colorectal adenoma formation [121].
PER3 alterations in cancer: cause or consequence?
Circadian disruption could be a consequence of cancer but
could also be a contributory factor in cancer development,
potentially through DNA methylation. The circadian tran-
scriptome of core clock genes and clock-controlled genes is
regulated by rhythmic epigenetic chromatin modiﬁcations via
histone acetylation and methylation, and the methylation of DNA
in promoter regions [122]. Disruption to the balance of this
epigenetic landscape could lead to disturbances in the rhythm of
the circadian transcriptome. A genome-wide study of DNA
methylation in lymphocytes found reduced levels of methylation
in nightshift workers compared to dayworkers [123]. Twenty-one
hyopmethylated loci were identiﬁed in clock genes in the night-
shift workers, with the three largest differences found in the gene
body of PER3. Gene body hypomethylation can lead to lower
expression levels and reduced expression of PER3 was found in
lymphocytes of rotating nightshift nurses [124]. Hypomethylation
of the PER3 promoter was also more frequent among patients with
colorectal adenomas [125]. In hepatocellular carcinomas (HCCs), a
genome-wide proﬁling study of promoter methylation identiﬁed
hypermethylation of PER3 in the HCCs compared to controls
together with reduced expression levels of PER3 [126]. Gene
promoter hypermethylation is associated with gene silencing and
the study showed that treatment designed to inhibit methylation
restored PER3 expression in the HCCs. These data point toward an
additional epigenetic modulation of PER3 expression that could
contribute to cancer.3 variants reveals widespread effects on circadian preference, sleep
.1016/j.smrv.2017.10.008
Research agenda
Although PER3 is often not considered a core clock gene, it
is one of the most robustly rhythmic genes. Variants of
PER3 have been investigated extensively and linked to a
wide variety of phenotypes. The latter may in part be due to
early positive findings which then led to an ‘over-investi-
gation’ of PER3 in candidate gene approaches. Alterna-
tively, PER3 may play an important role in driving temporal
organisation, in particular in non-SCN tissues.
For many of the reported associations it should be kept in
mind that sample sizes were often relatively small, and
failures to replicate may not have been reported. It is reas-
suring that GWAS studies have identified associations be-
tween PER3 variants and some phenotypes, but more and
larger studies are needed. It should also be noted that more
progress needs to bemade in understanding the underlying
molecular mechanisms and translating these to clinical
applications.
Phenotyping could also be more comprehensive and
include diverse sleepewake protocols, including not only
sleep restriction and sleep deprivation under constant
routine conditions and iterative napping, but also using
sleep extension, daytime napping, ad libitum sleep and
changes in the phase angle between sleep and circadian
rhythmicity (i.e., as in jet-lag, shift work). PER3 genotype-
dependent light sensitivity should also be characterised
by means of irradiance response curves to light and
different monochromatic and polychromatic light spectra.
Some of the phenotypes associated with PER3 variantsmay
be interrelated through a common mechanism. For
example, associations with diurnal preference, depression
and seasonal affective disorders may all be mediated by
effects of PER3 on light sensing and transduction processes
and their rhythmic modulation. Likewise, effects on cogni-
tion, sleep EEG, and response to sleep loss may be medi-
ated by effects on neuroanatomy or sleepewake dependent
changes in neural networks in conjunction with circadian
modulation of these networks. The associations between
PER3 variants and cancer may simply point to a general role
for PER3 in peripheral circadian organisation, which in turn
could interact with the cancer processes. For none of the
phenotypes associated with PER3 variants have molecular
mechanisms mediating the associations been identified,
although the effects of the PER3 VNTR knock in on sleep
homeostasis and activity related genes in mice may be
considered a first step. Research aimed at a better under-
standing of molecular mechanisms is warranted.
The PER3 VNTR polymorphism might contribute to shape
the cognitive ageing trajectory of an individual, through its
action on major sleepewake regulatory processes, but
further evidence including longitudinal studies on larger
cohorts is needed.
Comprehensive phenotyping, including simultaneous as-
sessments of EEG, sleep and cognition, as well as func-
tional and structural imaging of variants of other clock
genesmay provide new insights into the widespread effects
of circadian processes in health and disease.
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